About Us
Myomakers offers a bioengineering platform that artificially reconstructs and assesses musculoskeletal tissues for testing and research offering preclinical data from human cells. This platform integrates human skeletal muscle, neuronal (motor & sensory) and vascular cells, within a complex tissue environment that recreates the structure and function of human physiology.
Our Expert Team
Please meet our team
Professor Mark Lewis
CEO
Dr Andrew Capel
CSO
Tim King
CFO
Dr Kerry Chaplin
CBO
Dr Rowan Rimington
Advisor / Non Exec Director